Psychopharmacology Bulletin
SJR0.460
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.460 | Q3 | 57.9% | |
| 2024 | — | — | 0.561 | Q3 | 66.1% | |
| 2023 | — | — | 0.458 | Q3 | 62.0% | |
| 2022 | — | — | 0.328 | Q3 | 53.4% | |
| 2021 | — | — | 0.344 | Q3 | 55.7% | |
| 2020 | — | — | 0.285 | Q3 | 48.7% | |
| 2019 | — | — | 0.467 | Q3 | 65.5% | |
| 2018 | — | — | 0.525 | Q2 | 66.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
0048-5764
ISSN
2472-2448
region
Northern America
coverage
1963-1967, 1969-1998, 2001-2004, 2006-2012, 2016-2026